StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Mipafox

HCID 9738
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
371-86-8
Standard-SMILES
CC(C)NP(=O)(F)NC(C)C
InChIKey
UOSHUBFBCPGQAY-UHFFFAOYSA-N
Summenformel
C6H16FN2OP
Durchschnittliche Molmasse
182,18 g/mol
Monoisotopische Masse
182,0984283

Überblick

Mipafox is a phosphoramide.

Namen und Bezeichner

Bevorzugter Name
Mipafox
IUPAC
N-[fluoro-(propan-2-ylamino)phosphoryl]propan-2-amine
Lokaler Name
Mipafox
Englischer Name
N,N′-Diisoprophyl phosphordiamide fluoride
Summenformel
C6H16FN2OP
Molmasse
182.18

Namen und Synonyme

MIPAFOXIsopestox371-86-8Pestox XVN,N'-Diisopropylphosphorodiamidic fluoridePeston XVPestox 15Bis(isopropylamido) fluorophosphateDi(isopropylamido)phosphoryl fluoridePhosphorodi(isopropylamidic) fluorideBis(monoisopropylamino)fluorophosphateN,N'-Diisopropyldiamidophosphoryl fluoride
Weitere Namen anzeigen
Mipafox [ISO]DIISOPROPYLFLUORPHOSPHORAMIDE*Belumosudil Mesylate Impurity 113Fluorobis(isopropylamino)phosphine oxideN,N′-Diisoprophyl phosphordiamide fluoride
Bisisopropylaminofluorophosphine oxideBis(monoisopropylamino)fluorophosphine oxidePhosphine oxide, fluorobis(isopropylamino)-Bis(isopropylamido)fluorophosphatePhosphorodiamidic fluoride, N,N'-bis(1-methylethyl)-N,N'-Diisopropil-fosforodiammido-fluoruro24MJP5H3YNFluorobisisopropylaminophosphine oxide

Datenbank-Bezeichner

CAS
371-86-8
PubChem CID
9738
DTXSID
DTXSID5042160
ChEBI
CHEBI:82142
UNII
24MJP5H3YN
EC Number
206-742-3
Nikkaji
J5.710J

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1
Polarare Oberfläche (TPSA)
41,1 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
4
Schwere Atome
11
Formalladung
0
Komplexität
147

Experimentelle und physikochemische Eigenschaften

SpringerMaterials PropertiesBoiling point
PesticidesPesticides -> Organophosphate Insecticides
LogPlog Kow = 0.29 /Estimated/
OdorODORLESS
Density1.2 at 25 °C
Color/FormCrystals from petroleum ether
Solubility · 2 Einträge

Soluble in polar organic solvents and slightly soluble in petroleum ether.

In water, 80,000 mg/L at 25 °C

Boiling Point125 °C
DecompositionWhen heated to decomposition it emits very toxic fumes of /hydrogen fluoride as well as nitrogen and phosphorus oxides/.
Melting Point65 °C

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

Danger

H370 **: Causes damage to organs [Danger Specific target organ toxicity, single exposure]

P260, P264, P270, P308+P316, P321, P405, and P501 (click each P-code to see the statement)

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P260, P264, P270, P301+P316, P308+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Gefahrenhinweise

Hazards Summary · 1 Eintrag

A small number of the organophosphates (OPs) can Induce Delayed Neuropathy (OPIDN). OPIDN usually occurs after ingestion and is usually nonoccupational. [Levy, p. 431] Immediate and delayed neurotoxic effects observed in experimental animals; [HSDB] The average of two baseline respective cholinesterase activity determinations three days apart, with no exposures to enzyme inhibiting pesticides for at least 30 days, is recommended for each worker prior to exposure to cholinesterase inhibitors because of large inter-individual differences in published baseline values. To be established at least once a year. Removal from workplace exposures is recommended until the cholinesterase activity returns to within 20% of baseline. [TLVs and BEIs]

Hazard Classes and Categories · 3 Einträge

Acute Tox. 3 (100%)

Specific target organ toxicity (single exposure) - category 1

STOT SE 1

Shipment Methods and Regulations · 3 Einträge

No person may /transport,/ offer or accept a hazardous material for transportation in commerce unless that person is registered in conformance ... and the hazardous material is properly classed, described, packaged, marked, labeled, and in condition for shipment as required or authorized by ... /the hazardous materials regulations (49 CFR 171-177)./

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 4 Einträge

...Cholinesterase inhibitor.

The neurotoxic esterase fraction of hen brain microsomal phenyl-valerate-hydrolyzing activity is the target for mipafox.

A direct method of assaying neurotoxic esterase (NTE) activity, using 4-nitrophenyl valerate, was described. The technique was used to determine the bimolecular rate, phosphorylation and affinity constants for the reaction of chicken brain microsomal NTE with mipafox.

A number of... compounds such as... Mipafox... have the ability to bind tenaciously to the active site of acetylcholinesterase (AChE) and neuropathy target esterase (NTE) to produce an irreversibly inhibited enzyme by a mechanism known as aging. The aging process is dependent on the size and configuration of the alkyl (R) substituent, with the potency of the ester increasing in the order of diethyl, dipropyl, and dibutyl for such analogs as DFP and mipafox. The aging process is generally accepted as being caused by the dealkylation of the intermediate dialkylphosphorylated enzymes by one of two possible mechanisms. The first involves the hydrolysis of a P-O bond following a nucleophile (base) attack on the phosphorus atom. The second mechanism involves the hydrolysis of an O-C bond by an acid catalysis, resulting in the formation of a carbonium ion as the leaving group. The aging process is believed to fix an extra charge to the protein, causing some perturbation to the active site and thereby preventing dephosphorylation. While the exact nature of this reaction has not been demonstrated for AChE and NTE, evidence from experiments with saligenin cyclic phosphorus esters (derivative of TOTP) and alpha-chymotrypsin points to the possibility of two stabilized forms of "aged" enzyme. Both of the reactions utilize the imidazole group of a neighboring histidine. In one reaction, the hydroxylated substituent is released and the phosphorylated enzyme is stabilized by a hydrogen on the imidazole group. In the other reaction, the leaving substituent becomes attached to the imidazole, yielding a N-C hydroxylated derivative of the phosphorylated enzyme.

Biological Half-Life...Decomposition... by enzymes of plants... half life is 7-8 days.
Metabolism/Metabolites/Direct cholinesterase inhibitors/...group includes...mipafox.../and/ compounds exerting direct inhibitory action...are rapidly hydrolyzed both physically and enzymically as soon as they reach tissues.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Vapor Pressure · 2 Einträge

0.001 [mmHg]

0.001 mm Hg at 15 °C

Henry's Law ConstantHenry's Law constant = 3.0X10-9 atm-cu m/mole at 15 °C /Estimated/

Physikochemische Eigenschaften

Schmelzpunkt
65 ° · 65°
Siedepunkt
125.5 °C · 125.5°C
Dichte
1.2 g/cm3 · 1.2 g/cm3(Temp: 25 °C)
pka
-2.71 · -2.71±0.70(Predicted)
Aggregatzustand
solid
Wasserlöslichkeit
74.07 g/L · 74.07g/L(temperature not stated)
Henry's Law Constant
3.3 · 3.3×103 mol/(m3Pa) at 25℃, HSDB (2015)
EPA chemische Informationen
Mipafox (371-86-8)

The International Air Transport Association (IATA) Dangerous Goods Regulations are published by the IATA Dangerous Goods Board pursuant to IATA Resolutions 618 and 619 and constitute a manual of industry carrier regulations to be followed by all IATA Member airlines when transporting hazardous materials.

The International Maritime Dangerous Goods Code lays down basic principles for transporting hazardous chemicals. Detailed recommendations for individual substances and a number of recommendations for good practice are included in the classes dealing with such substances. A general index of technical names has also been compiled. This index should always be consulted when attempting to locate the appropriate procedures to be used when shipping any substance or article.

Shipping Name/ Number DOT/UN/NA/IMOUN 2783; MIPAFOX

Sicherheit und Schutzausrüstung

Exposure Control and Personal Protection · 1 Eintrag

Biological Exposure Indices (BEI) [ACGIH] - Acetylcholinesterase activity in red blood cells = 70% of individual's baseline; Butylcholinesterase activity in serum or plasma = 60% of individual's baseline; Sample at end of shift; [TLVs and BEIs]

Disposal Methods · 1 Eintrag

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Toxikologische Informationen

Interactions · 2 Einträge

The effects of aldicarb and verapamil on mipafox (371868) induced inhibition of neuropathy-target-esterase (NTE) activity in human neuroblastoma cells were examined. Differentiated SY-5Y (SY5Y) cells, a cell line derived from SK-N-SH-human neuroblastoma cells, were incubated with 0 or 5x10(-5) molar (M) mipafox in the presence or absence of 5x10(-3)M aldicarb or 1x10(-7)M verapamil for 2 to 10 minutes. The cultures were assayed for NTE activity. The ability of 25 millimolar isonitroacetophenone (INAP) to reactivate NTE activity was evaluated 2, 5, or 10 minutes after mipafox exposure. A similar experiment was performed in chicken brain homogenates. Mipafox caused a similar time dependent decrease of NTE activity in SY5Y cells and chicken brain homogenates. INAP was capable of reactivating NTE activity; however, the degree of reactivation decreased with increasing time between mipafox and INAP treatment. Aldicarb and verapamil countered the inhibitory effect of mipafox in both SY5Y cells and the brain homogenates. The authors conclude that NTE activity in SY5Y cells and chicken brain homogenates, the accepted model for organophosphate induced delayed neuropathy (OPIDN), is inhibited to a similar extent by mipafox. Aldicarb and verapamil exert inhibitory effects on the mipafox induced suppression of NTE activity in both preparations.

The toxic effects of phenylmethylsulfonyl-fluoride (329986) (PMSF) and Mipafox (371868), administered either singly or combined, were studied in 60 day old male Long-Evans-rats. Animals were treated with: 250 milligrams per kilogram (mg/kg) PMSF; 15mg/kg Mipafax; 250mg/kg PMSF followed 4 hours later by 15mg/kg Mipafax; 15mg/kg Mipafox followed 4 hours later by 250mg/kg PMSF; or 250mg/kg PMSF followed 14 days later by 15mg/kg Mipafax. Animals receiving single doses of either compound were sacrificed 1, 4, 24, 48, or 72 hours after administration and others were sacrificed 14 to 21 days postexposure. Assays were conducted to determine evidence of neuropathy, target enzyme, and damage to cervical cord. Animals receiving PMSF only were incapacitated for 48 hours and then resumed normal activity; no mortality occurred. Mipafox only animals experienced mild tremors and diarrhea; no mortality occurred in this group either. Animals receiving Mipafox 4 hours after PMSF had a 50 percent mortality rate and remained immobile for 48 hours after treatment. Animals receiving PMSF 4 hours after Mipafox had tremors which were eliminated after PMSF treatment which immobilized them for 48 hours; a 25 percent mortality rate occurred. There were no deaths among animals receiving Mipafox 14 days after PMSF, although the animals were similarly incapacitated.

Environmental Fate · 3 Einträge

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 8.8(SRC), determined from a water solubility of 80,000 mg/L(2) and a regression-derived equation(3), indicates that mipafox is expected to have very high mobility in soil(SRC). Volatilization of mipafox from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant for mipafox of 3.0X10-9 atm-cu m/mole(SRC) derived from its vapor pressure, 0.001 mm Hg(4), and water solubility(2). Mipafox is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(4). Biodegradation data were not available(SRC, 2005).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 8.8(SRC), determined from a water solubility of 80,000mg/L(2) and a regression-derived equation(3), indicates that mipafox is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant for mipafox of 3.0X10-9 atm-cu m/mole(SRC) derived from its vapor pressure, 0.001 mm Hg(4), and water solubility(2). According to a classification scheme(6), an estimated BCF of 1(SRC), determined from its water solubility(5) and a regression-derived equation(3), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Mipafox is reported to hydrolyze slowly under environmental conditions; a half life of 200 days was observed at pH 6(4). Biodegradation data were not available(SRC, 2005).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), mipafox, which has a vapor pressure of 0.001 mm Hg at 25 °C(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase mipafox is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 4.2 hrs(SRC), calculated from its rate constant of 9.2X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Mipafox does not contain chromophores that absorb at wavelengths >290 nm and therefore would not be expected to be susceptible to direct photolysis by sunlight(SRC).

Adverse EffectsNeurotoxin - Predominantly motor
Soil Adsorption/Mobility · 1 Eintrag

The Koc of mipafox is estimated as 8.8(SRC) using a water solubility of 80,000 mg/L(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that mipafox is expected to have very high mobility in soil.

Human Toxicity Excerpts · 3 Einträge

/HUMAN EXPOSURE STUDIES/ ...Acetylcholinesterase inhibitor, like parathion. After acute phases of poisoning, degenerative lesions may become apparent in central and peripheral nervous systems.

/SIGNS AND SYMPTOMS/ ...Some cholinesterase-inhibiting organophosphorus compounds can produce permanent paralysis due to /PRC: secondary/ demyelinating process of spinal cord... Demyelination in man has been attributed only to mipafox, agent not used in United States.

/SIGNS AND SYMPTOMS/ See Parathion. Symptomatology: 1. Nausea...vomiting, abdominal cramps, diarrhea, excessive salivation... 2. Headache, giddiness, vertigo and weakness. 3. Rhinorrhea and sensation of tightness in chest are common in inhalation exposure. 4. Blurring or dimness of vision, miosis... Tearing, ciliary muscle spasm, loss of accommodation and ocular pain... Mydriasis...sometimes seen...probably due to sympatho-adrenal discharge. 5. Loss of muscle coordination, slurring of speech, fasciculations and twitching of muscles (particularly of tongue and eyelids), and generalized profound weakness. 6. Mental confusion, disorientation and drowsiness. 7. Difficulty in breathing, excessive secretion of saliva and of respiratory tract mucus, oronasal frothing, cyanosis, pulmonary rales and rhonchi and hypertension (presumably due to asphyxia). 8. Random jerky movements, incontinence, convulsions, and coma. 9. Death primarily due to respiratory arrest arising from failure of respiratory center, paralysis of respiratory muscles, intense bronchoconstriction or all three. /Parathion/

Artificial Pollution SourcesMipafox's former production and use as an insecticide(1) resulted in its direct release to the environment(SRC).
Environmental Bioconcentration · 1 Eintrag

An estimated BCF of 1 was calculated for mipafox(SRC), determined from a water solubility of 80,000 mg/L(1) and a regression-derived equation(2). According to a classification scheme(2), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC).

Volatilization from Water/Soil · 1 Eintrag

The Henry's Law constant for mipafox is estimated as 3.0X10-9 atm-cu m/mole(SRC) derived from its vapor pressure, 0.001 mm Hg(1), and water solubility, 80,000 mg/L(2). This Henry's Law constant indicates that mipafox is expected to be essentially nonvolatile from water surfaces(3). Mipafox's estimated Henry's Law constant indicates that volatilization from moist soil surfaces is not expected to occur(SRC). Mipafox is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(1).

Non-Human Toxicity Excerpts · 5 Einträge

/LABORATORY ANIMALS: Acute Exposure/ Mipafox produces demyelinating lesions in spinal cord and peripheral nerves. In...experimental animals, after apparent recovery from... attack of acute poisoning, muscular weakness has later developed... Should lesions be found, these are usually secondary to symptoms, eg pulmonary edema, asphyxia, gastroenteritis, etc.

/LABORATORY ANIMALS: Acute Exposure/ ... This study assesses the occurrence of the necrotizing myopathy in rats in relation to the clinical course and the acetylcholinesterase (AChE) inhibition after poisoning with organophosphates representative for each of the major types of organophosphate-related neurotoxicity. Marked differences are noted in the duration of cholinergic symptoms and of AChE inhibition after either paraoxon and mipafox, or fenthion poisoning. The necrotizing myopathy begins shortly after the initial decline in AChE activity with all organophosphates studied. Maximal muscle involvement occurs within the first 2 days of the poisoning with all organophosphates studied. The myopathy is not aggravated by a further decline in AChE activity in fenthion poisoning.

/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Adult male albino mice were given single subcutaneous injections of either mipafox (110 mumol/kg) or ecothiopate (0.5 mumol/kg), two organophosphorus compounds (OPs). Acetylcholinesterase activity was measured in the soleus (slow-twitch) and extensor digitorum longus (EDL; fast-twitch) muscles. At 7 and 28 days after dosing, in vitro electrophysiological measurements were carried out in the soleus and EDL. Action potentials and end-plate potentials were evoked at 30 Hz and recorded intracellularly from single muscle fibers. The amplitudes, time course, and latencies of these potentials were measured and the variability (jitter) of latencies was calculated. Recordings after mipafox were also made with 3-Hz stimulation. Acetylcholinesterase activity was inhibited by mipafox (65% in the soleus; 76% in the EDL) and ecothiopate (59% in the soleus; 42% in the EDL). Mipafox and ecothiopate both increased postjunctional (muscle action potential) jitter in the soleus and EDL at 7 days after dosing. Organophosphates caused an increase in end-plate potential amplitudes in the soleus. Mipafox caused an increase in prejunctional (end-plate potential) jitter at 28 days after dosing in both muscles. A single dose of ecothiopate also caused an increase in prejunctional jitter at 28 days in the soleus. The OP-induced increase in jitter was different at different frequencies of stimulation.

/LABORATORY ANIMALS: Neurotoxicity/ Hens treated with Mipafox (10 mg/kg, sc), daily for 10 days exhibited severe, moderate and no ataxia respectively on 14th day after the start of exposure. The neurotoxic esterase (NTE) activity was significantly inhibited in the brain, spinal cord and platelets of hens treated with mipafox or sarin whereas no change was noticed with parathion treatment. All three compounds significantly inhibited acetylcholinesterase (AChE) activity in the platelets. Spinal cord of hens treated with mipafox, sarin or parathion showed axonal degeneration heavy, moderate and none respectively.

Environmental Abiotic Degradation · 1 Eintrag

The rate constant for the vapor-phase reaction of mipafox with photochemically-produced hydroxyl radicals has been estimated as 9.2X10-11 cu cm/molecule-sec at 25 °C(SRC) using a structure estimation method(1). This corresponds to an atmospheric half-life of about 4.2 hours at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). Mipafox is reported to hydrolyze slowly under environmental conditions; a half life of 200 days was observed at pH 6(2). Mipafox does not contain chromophores that absorb at wavelengths >290 nm and therefore would not be expected to be susceptible to direct photolysis by sunlight(SRC).

Probable Routes of Human Exposure · 1 Eintrag

Occupational exposure and general population exposure should be low or non-existent since mipafox is no longer produced or used. In the past, mipafox was applied directly to plants as an insecticide and exposure to this compound was primarily by inhalation and dermal contact. (SRC)

Environmental Fate/Exposure Summary · 1 Eintrag

Mipafox's former production and use as an insecticide resulted in its direct release to the environment. If released to air, a vapor pressure of 0.001 mm Hg at 15 °C indicates mipafox will exist solely as a vapor in the ambient atmosphere. Vapor-phase mipafox will be degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals; the half-life for this reaction in air is estimated to be 4.2 hours. Mipafox does not absorb light with wavelengths >290 nm and therefore would not be expected to be susceptible to direct photolysis by sunlight. If released to soil, mipafox is expected to have very high mobility based upon an estimated Koc of 8.8. Volatilization from moist soil surfaces is not expected to be an important fate process based upon an estimated Henry's Law constant of 6.3X10-10 atm-cu m/mole. Mipafox is not expected to volatilize from dry soil surfaces based upon its vapor pressure. If released into water, mipafox is not expected to adsorb to suspended solids and sediment based upon the estimated Koc. Volatilization from water surfaces is not expected to be an important fate process based upon this compound's estimated Henry's Law constant. An estimated BCF of 1 suggests the potential for bioconcentration in aquatic organisms is low. Mipafox is reported to hydrolyze slowly; under environmental conditions a half life of 200 days was observed at pH 6. Occupational exposure and general population exposure should be low or non-existent since currently mipafox is no longer produced or used in the US (May, 2005). In the past, mipafox was applied directly to plants as an insecticide and exposure to this compound was primarily by inhalation and dermal contact. (SRC)

Sicherheitsdaten

ridadr
2783
risk_code
39/26/27/28
Toxizität
Formerly used as a systemic insecticide. Its use was discontinued because of severe delayed neuropathy hazard in humans. The oral LD50/LC50 in rabbits is 100 mg/kg. Toxic action is as a neurotoxicant with both acute and delayed actions, acting as a cholinesterase inhibitor (acute toxicity) and as a neurotoxic esterase inhibitor (possibly linked to delayed toxicity). Symptoms in humans are typical anticholinesterase symptoms. Therapy is supportive as well as atropine sulfate and 2-PAM.
hazard_code
T+
safety_code
13-45
hazard_class
6.1(b)
packing_group
III
Giftige Stoffe Daten
371-86-8(Hazardous Substances Data)

Verwendung und Herstellung

Uses · 6 Einträge

Used as an insecticide; [Merck Index] Used in neurotoxicology studies; [HSDB]

Not used in the US; [HSDB] This chemical ingredient is not found in any products. [NPIRS]

Farming (Pesticides) [Category: Industry]

For mipafox (USEPA/OPP Pesticide Code: 356300) there are 0 labels match. /SRP: Not registered for current use in the U.S., but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./

Insecticide /SRP 2005: Former use/

Investigative chemical for neurotoxicology studies

ImpuritiesMain impurities of commercial product are hydrolytic products & the Isopropylamide of orthophosphoric acid...
Methods of Manufacturing · 2 Einträge

By reaction of isopropylamine with POCl3 in inert anhydrous solvent & treatment of product with strong aqueous solution of potassium or ammonium fluoride.

Pound et al, GB 688787 (1953 to Fisons)

Formulations/PreparationsFor experimental use: anhydrous solution (50% active ingredient) with wetting agent. Usually applied as spray in concn 0.5-1.0% active ingredient.
General Manufacturing Information · 2 Einträge

Has been withdrawn from market being suspect as cause of paralysis of two operators...

/It is/ absorbed & translocated by plant which is rendered systemically insecticidal to sap-feeding insects & mites.

Anwendungen

VerwendenInsecticide.

For more Non-Human Toxicity Excerpts (Complete) data for MIPAFOX (29 total), please visit the HSDB record page.